These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 7241386)
21. [The effect of quaternary salts of exaprolol on disorders of cardiac rhythm in experimental myocardial infarct]. Kittová M; Drímal J Bratisl Lek Listy; 1984 Aug; 82(2):963-72. PubMed ID: 6149002 [No Abstract] [Full Text] [Related]
22. [Anti-arrhythmic properties of specific bradycardic agents from the group of 2-mercaptobenzimidazole derivatives]. Chichkanov GG; Tsorin IB; Kirsanova GIu; Berdiaev SIu; Turilova AI Eksp Klin Farmakol; 1997; 60(5):35-9. PubMed ID: 9483403 [TBL] [Abstract][Full Text] [Related]
23. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo. Sun W; Wainwright CL Coron Artery Dis; 1994 Jun; 5(6):541-50. PubMed ID: 7952414 [TBL] [Abstract][Full Text] [Related]
24. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model. Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Stamatoyannis N; Molyvdas PA J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223 [TBL] [Abstract][Full Text] [Related]
25. Effects of SM-20550 against myocardial infarction-induced arrhythmias, late infarct expansion, and left ventricular dysfunction. Grosjean N; Vié B; Létienne R; Le Grand B J Cardiovasc Pharmacol; 2007 Nov; 50(5):563-70. PubMed ID: 18030067 [TBL] [Abstract][Full Text] [Related]
26. Synergistic interaction between class I antiarrhythmic drugs and halothane in depressant effects on ventricular activation in a canine myocardial infarction model. Hashimoto H; Imamura S; Ikeda K; Nakashima M Biol Pharm Bull; 1994 Mar; 17(3):449-53. PubMed ID: 8019516 [TBL] [Abstract][Full Text] [Related]
27. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties. Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677 [TBL] [Abstract][Full Text] [Related]
28. [The effects of propafenone in the treatment of ventricular arrhythmias with a malignant potential for resistance to conventional anti-arrhythmia medication]. Câmpeanu A; Rădoi M; Serban-Pârâu G; Pleşca O; Nuţă M; Teodorescu V; Titirigă M Med Interna; 1993; 45(1-2):35-41. PubMed ID: 8081689 [No Abstract] [Full Text] [Related]
29. [Ventricular arrhythmias: diagnosis and drug therapy]. Schüpfer C; Gertsch M Praxis (Bern 1994); 1996 May; 85(20):647-54. PubMed ID: 8685556 [TBL] [Abstract][Full Text] [Related]
30. Antiarrhythmic effect related to the plasma concentration of pentisomide in vivo and the antiarrhythmic-concentration relationship in vitro. Hachisu M; Chen H; Soneda T; Fujishima K; Ishizuka T; Konno F Drugs Exp Clin Res; 1995; 21(4):145-51. PubMed ID: 8529527 [TBL] [Abstract][Full Text] [Related]
31. Study on the antiarrhythmic effects of some centrally acting drugs--benzodiazepines. Kuruvilla A; Stephen PM Indian J Exp Biol; 1983 Jan; 21(1):23-6. PubMed ID: 6138308 [No Abstract] [Full Text] [Related]
32. [Anti-arrhythmic activity of quaternary derivatives of trimecaine in experimental ventricular arrhythmias]. Gendenshteĭn EI; Tsybusov AP; Zhukauskaĭte LN; Stankevichius AP Biull Eksp Biol Med; 1982 Nov; 94(11):55-7. PubMed ID: 7150740 [No Abstract] [Full Text] [Related]
33. Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin. Gandhi C; Upaganalawar A; Balaraman R Free Radic Res; 2009 Sep; 43(9):817-27. PubMed ID: 19579067 [TBL] [Abstract][Full Text] [Related]
34. Proton relaxation enhancement in tissue due to ingested manganese chloride: time course and dose response in the rat. Mamourian AC; Burnett KR; Goldstein EJ; Wolf GL; Kressel HY; Baum S Physiol Chem Phys Med NMR; 1984; 16(2):123-8. PubMed ID: 6334323 [TBL] [Abstract][Full Text] [Related]
35. The effects of manganese on aconitine-induced ventricular tachycardia. Puletti M; Mariani M; Jacobellis GF; Coletti G; Perego MA Arch Fisiol; 1973 Dec; 70(3-4):233-41. PubMed ID: 4807473 [TBL] [Abstract][Full Text] [Related]
36. Effects of valinomycin and MnCl2 on the ventricular fibrillation threshold and on aconitine-induced arrhythmia. Liu S; Huang TF Taiwan Yi Xue Hui Za Zhi; 1982 Jul; 81(7):903-9. PubMed ID: 6292326 [No Abstract] [Full Text] [Related]
37. oxicity of diphenylhyntoin in dogs with experimental myocardial infarction. Nigri A; da Costa BC; Scriabine A; Bellet S; Germiniani H Cardiologia (Basel); 1968; 53(3):150-7. PubMed ID: 5736953 [No Abstract] [Full Text] [Related]
38. Antiarrhythmic agents. 2-, 3-, And 4-substituted benzylamines. Remy DC; Van Saun WA; Engelhardt EL J Med Chem; 1975 Feb; 18(2):142-8. PubMed ID: 1120980 [TBL] [Abstract][Full Text] [Related]
39. Effects of the rauwolfia alkaloids, ajmaline, tetraphyllicine, and serpentine, on myocardial excitability. Duncan RJ; Nash CB Arch Int Pharmacodyn Ther; 1970 Apr; 184(2):355-61. PubMed ID: 5453235 [No Abstract] [Full Text] [Related]
40. [N-acetylcysteine: its effect on myocardial infarct in dogs]. Sochman J; Kolc J; Vrána M; Fabián J Cesk Fysiol; 1990; 39(6):513-6. PubMed ID: 2083443 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]